<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97292">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01698957</url>
  </required_header>
  <id_info>
    <org_study_id>UA Doppler 2012</org_study_id>
    <nct_id>NCT01698957</nct_id>
  </id_info>
  <brief_title>Maternal Uterine Artery Doppler Study</brief_title>
  <official_title>A Simple Technique to Modify Maternal Uterine Artery Perfusion.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Obstetrix Medical Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Obstetrix Medical Group</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to detect if adding resistance to maternal blood flow from the
      arm will help increase the blood flow through the uterine arteries to the placenta and the
      baby.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the setting of uteroplacental insufficiency, there is little that can be done to increase
      blood flow through the uterus and placenta.  Historically, women with growth restricted
      fetuses or oligohydramnios have been placed on bed rest.  Unfortunately, this treatment
      modality has met with only limited success.  Cardiologists have long recognized the simple
      act of making a fist or otherwise occluding blood flow through a limb dramatically increases
      a person's peripheral vascular resistance.  If maternal peripheral resistance can be
      increased, perhaps the increased differential between the maternal peripheral vascular
      resistance and that of the uteroplacental unit will increase flow through the uterus and
      placenta.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Uterine Artery Doppler</measure>
    <time_frame>at time of routine ultrasound</time_frame>
    <safety_issue>No</safety_issue>
    <description>The purpose of this study is to detect if adding resistance to maternal blood flow from the arm will help increase the blood flow through the uterine arteries to the placenta and the baby.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pregnant Women</condition>
  <condition>Greater Than or Equal to 18 Weeks Gestation</condition>
  <condition>Uterine Artery Doppler</condition>
  <arm_group>
    <arm_group_label>UA Doppler Velocimetry</arm_group_label>
    <description>Any patient eligible for an Ultrasound greater than or equal to 18 weeks gestation without a fetal or uterine anomaly.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Any patient eligible for an Ultrasound greater than or equal to 18 weeks gestation without a fetal or uterine anomaly.</intervention_name>
    <arm_group_label>UA Doppler Velocimetry</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women greater than or equal to 18 weeks gestation and 18 years old eligible for
        an ultrasound without fetal or uterine anomalies
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women greater than or equal to 18 years old

          -  Able to speak and read English

          -  Have a singleton pregnancy greater than or equal to 18 weeks gestation

        Exclusion Criteria:

          -  Multiple gestation

          -  Less than 18 weeks gestation

          -  Uterine anomalies

          -  Fetal anomalies

          -  Preeclampsia

          -  Hypertension

          -  Inability to have BP cuff on left arm
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas H Strong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Obstetrix Medical Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Phoenix Perinatal Associates</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Bodea-Braescu, MSN, MPH</last_name>
      <phone>602-614-0488</phone>
      <email>ana_braescu@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Thomas H Strong, MD</last_name>
      <phone>602-677-9234</phone>
      <email>thomas_strong@obstetrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas H Strong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenix Perinatal Associates</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Bodea-Braescu, MSN, MPH</last_name>
      <phone>602-614-0488</phone>
      <email>ana_braescu@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Thomas H Strong, MD</last_name>
      <phone>602-677-9234</phone>
      <email>thomas_strong@obstetrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas H Strong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 9, 2013</lastchanged_date>
  <firstreceived_date>October 1, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnant women</keyword>
  <keyword>Uterine Artery Doppler Velocimetry</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
